If you have been eyeing Essity (OM:ESSITY B) lately, you are not alone. Recent moves in the stock may have caught your attention and have investors quietly wondering if there is a deeper story unfolding. While no single headline has driven this latest shift, the slight upswing over the past month, even after a choppier stretch earlier this year, has sparked fresh debate about where Essity goes next. With market sentiment shifting back and forth, it is only natural to ask whether the current price reflects the company’s true potential.
Over the past year, Essity’s stock has lagged its longer-term performance. Returns have been negative year-to-date and over the past twelve months, even as the stock has started inching up again in the last month. Looking further back, returns over three and five years show some growth, but recent momentum has been mixed, and new catalysts seem scarce.
After a stretch like this, is the market offering a window for value-oriented buyers, or does the recent uptick simply reflect expectations for brighter days ahead?
Advertisement
Most Popular Narrative: 10.9% Undervalued
The most widely followed valuation narrative sees Essity as trading below its calculated fair value, factoring in future earnings growth, profit margins, and key business drivers.
Innovations in premium, eco-friendly, and coreless products, along with industry recognition for sustainability, position Essity to capitalize on shifting consumer preference for sustainable and higher-value tissue and hygiene products. This supports both topline growth and margin expansion.
What is really fueling this bold valuation? The key financial estimates, the profit trajectory, and a surprising future earnings target are all hidden in plain sight. The narrative leans on underlying demand shifts and strategic bets, hinting at some aggressive growth expectations that could reshape the outlook. Ready to uncover the projections that drive the fair value math?
However, persistent weak volume growth in key categories or rising costs could quickly undermine current expectations and present challenges to the case for sustained upside.
While many see Essity as undervalued based on where analysts have set their price targets, our SWS DCF model also suggests the shares are trading below fair value when considering long-term cash flows. Does this second approach boost your confidence, or does it raise new questions?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Essity for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own Essity Narrative
If you think there is more to Essity’s story, or if you like to explore the data for yourself, you can quickly craft your own view and test your ideas here: Do it your way.
Top investors never settle for just one opportunity. Give yourself an edge by using our smart screeners to spot stocks with real momentum and future potential. Don’t let these fast-moving trends pass you by. Strong returns could be waiting for you.
Tap into future-defining technology by tracking companies at the forefront of quantum breakthroughs with quantum computing stocks.
Secure consistent income streams by finding top performers offering above-average yields through dividend stocks with yields > 3%.
Spot potential bargains primed for growth using our tool that highlights shares trading below their cash flow worth, like undervalued stocks based on cash flows.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Essity might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Kshitija (or Keisha) Bhandaru is an Equity Analyst at Simply Wall St and has over 6 years of experience in the finance industry and describes herself as a lifelong learner driven by her intellectual curiosity. She previously worked with Market Realist for 5 years as an Equity Analyst.
